BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38724507)

  • 1. Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome.
    Rigo A; Vaisitti T; Laudanna C; Terrabuio E; Micillo M; Frusteri C; D'Ulivo B; Merigo F; Sbarbati A; Mellert K; Möeller P; Montresor A; Di Napoli A; Cirombella R; Butturini E; Massaia M; Constantin G; Vinante F; Deaglio S; Ferrarini I
    Cell Death Dis; 2024 May; 15(5):323. PubMed ID: 38724507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
    Akl H; Vervloessem T; Kiviluoto S; Bittremieux M; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2240-52. PubMed ID: 24768714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia.
    Cobo F; Martínez A; Pinyol M; Hernández L; Gómez M; Beá S; Esteve J; Rozman M; Bosch F; López-Guillermo A; Montserrat E; Campo E
    Leukemia; 2002 Jun; 16(6):1028-34. PubMed ID: 12040434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.
    Davids MS; Deng J; Wiestner A; Lannutti BJ; Wang L; Wu CJ; Wilson WH; Brown JR; Letai A
    Blood; 2012 Oct; 120(17):3501-9. PubMed ID: 22955911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
    Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
    Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia.
    Patel V; Chen LS; Wierda WG; Balakrishnan K; Gandhi V
    Leuk Lymphoma; 2014 Apr; 55(4):899-910. PubMed ID: 23837491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia.
    Deng J; Isik E; Fernandes SM; Brown JR; Letai A; Davids MS
    Leukemia; 2017 Oct; 31(10):2075-2084. PubMed ID: 28111464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BH3-only protein Noxa is stimulated during apoptosis of chronic lymphocytic leukemia cells triggered by M2YN, a new plant-derived extract.
    Zaher M; Mirshahi M; Nuraliev Y; Sharofova M; Bombarda I; Marie JP; Billard C
    Int J Oncol; 2011 Oct; 39(4):965-72. PubMed ID: 21750864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
    Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.
    Pérez-Galán P; Roué G; López-Guerra M; Nguyen M; Villamor N; Montserrat E; Shore GC; Campo E; Colomer D
    Leukemia; 2008 Sep; 22(9):1712-20. PubMed ID: 18596739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic leukemia transformation into high-grade lymphoma: a description of Richter's syndrome in eight dogs.
    Comazzi S; Martini V; Riondato F; Poggi A; Stefanello D; Marconato L; Albonico F; Gelain ME
    Vet Comp Oncol; 2017 Jun; 15(2):366-373. PubMed ID: 26463596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperforin induces apoptosis of chronic lymphocytic leukemia cells through upregulation of the BH3-only protein Noxa.
    Zaher M; Tang R; Bombarda I; Merhi F; Bauvois B; Billard C
    Int J Oncol; 2012 Jan; 40(1):269-76. PubMed ID: 21947285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis.
    Siegmund B; Welsch J; Loher F; Meinhardt G; Emmerich B; Endres S; Eigler A
    Leukemia; 2001 Oct; 15(10):1564-71. PubMed ID: 11587214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic.
    Ghiotto F; Fais F; Tenca C; Tomati V; Morabito F; Casciaro S; Mumot A; Zoppoli G; Ciccone E; Parodi S; Bruno S
    Cancer Biol Ther; 2009 Feb; 8(3):263-71. PubMed ID: 19164937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
    Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutics targeting Bcl-2 in hematological malignancies.
    Ruefli-Brasse A; Reed JC
    Biochem J; 2017 Oct; 474(21):3643-3657. PubMed ID: 29061914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies.
    Ten Hacken E; Valentin R; Regis FFD; Sun J; Yin S; Werner L; Deng J; Gruber M; Wong J; Zheng M; Gill AL; Seiler M; Smith P; Thomas M; Buonamici S; Ghia EM; Kim E; Rassenti LZ; Burger JA; Kipps TJ; Meyerson ML; Bachireddy P; Wang L; Reed R; Neuberg D; Carrasco RD; Brooks AN; Letai A; Davids MS; Wu CJ
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL.
    Tzankov A; Fong D
    Med Hypotheses; 2006; 66(3):577-9. PubMed ID: 16223567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.
    Filip AA; Ciseł B; Wąsik-Szczepanek E
    Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia.
    Zhang LN; Li JY; Xu W
    Cancer Gene Ther; 2013 Jan; 20(1):1-7. PubMed ID: 23175245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.